CCRM supports the development & commercialization of regenerative medicines & associated enabling technologies, with a specific focus on cell & gene therapy.
We're pleased to share our 2025 #annualreport: Reimagining The Possible. It was a year defined by resilience, focus & forward momentum. Read about our collab w/ @IonQ_Inc, progress w/ @CCRM_au & Nordic, successes at our #GMP#CDMO & @CATTI_Training & more https://t.co/jfDPHZVleh
There's promising new research for preventing fractures, but the personalized nature of the treatment will be expensive and difficult to scale. Is an off-the-shelf product possible? Read the post and share your thoughts. #menopause
Last week, IR #SantPau took part in the Catalonia-Sweden Health Innovation Mission in Gothenburg and the Västra Götaland Region🌟
����Organized by the Delegation of the Government of Catalonia and Biocat, the mission connected Catalonia with Swedish life-science ecosystems, with the aim of fostering a more resilient and competitive future.
💡Our institute was represented by Sergio Gonzalez, Head of Internationalization & Global Development.
💭The mission focused on Advanced Therapy Medicinal Products (ATMPs) as the main axis for cooperation. The goal was to connect regional policy, hospitals and industry to strengthen our joint European positioning and promote new collaboration pipelines between institutions from both regions.
🔬The programme included visits to leading innovation and clinical hubs, such as Sahlgrenska University Hospital, GoCo Health Innovation City, CCRM Nordic and AstraZeneca.
🌎A major highlight was the exploration of joint EU-funded opportunities around the ATMP roadmap and health data, aiming to increase cross-regional impact through Horizon Europe.
🗣️The mission culminated in the “Health Systems Dialogue across Europe” forum, which featured a keynote on regional cooperation by Anna-Pia Papageorgiou from the European Commission, as well as panels dedicated to the ATMP roadmap for Europe’s competitiveness.
🫱🏾🫲🏽We would like to thank the Delegation of the Government of Catalonia and Biocat, as well as the Swedish organizers, GoCo Health Innovation City, CCRM Nordic and Region Västra Götaland, for their welcome and for making this exchange possible.
#TogetherWeDoResearch
Companies at BIO-Europe said shifting U.S. politics have created an opening to promote Canada’s strengths to European partners.
https://t.co/h3B8IIiMdh
Novartis Confirms Nine Cases of Tumors in Children Treated with Gene Therapy Zolgensma
@Novartis has confirmed nine instances in which #tumors have developed in children treated with its marketed spinal muscular atrophy #genetherapy Zolgensma®
#GENEdge
https://t.co/H2h3RJbSrb
Breakthroughs in Cell + Gene Therapy kicks off this Thursday! There's still time to join us virtually so you can stay up-to-date on all things CGT without the travel.
Plus, registrants get on-demand access to all sessions from Breakthroughs for one year.
Learn more and register now at https://t.co/NkijPtGl9G
#DeepTechBioLab is in Cambridge, MA, this month, exploring how to accelerate #CGT through AI, quantum and robotics. Connect with Dr. Jessica Tate:
📍 Nov. 17: @ISCTglobal Signature Series on AI
📍 Nov. 19: Entangled Summit @LabCentral@c10labs@ICDK_CPH DM us to book a 1:1 chat
November is #DiabetesAwarenessMonth, which serves as an opportunity to recognize how #Type1Diabetes (#T1D) impacts people who live with the disease and the broader community who supports them. To learn more about T1D, visit the @BeyondType1 website: https://t.co/5MpmDpoA2J
Ontario can boast exciting, innovative and transformational life sciences companies and organizations. Read @LifeSciencesON's Success Stories 2026. CCRM is pleased to be featured again this year. Find us on page 12 and check out #OmniaBio on page 38.
https://t.co/fjFCLgT8Ng
Cal Strode, a @Signalsblogs blogger himself, goes back to a post in 2016 to hold our bloggers accountable for predictions they made about the future of #iPSCs. How did they do? Read on.
How good are you at making predictions? Blogger Cal Strode checks in on some #iPSC predictions made in 2016 as the #stemcell field celebrates 20 years of progress. https://t.co/D3S4E08Udl @ISSCR@KyotoU_News
How good are you at making predictions? Blogger Cal Strode checks in on some #iPSC predictions made in 2016 as the #stemcell field celebrates 20 years of progress. https://t.co/D3S4E08Udl @ISSCR@KyotoU_News
Mark your calendar for IonQ's Q3 2026 earnings call on Thursday, November 5 at 4:30 pm ET.
Join us to hear Chairman & CEO @NiccoloDeMasi and COO & CFO Inder Singh as they share our financial results and business highlights.
Register for the earnings call → https://t.co/KfNiWMTqxm
#IonQ #QuantumIsNow #FutureOfQuantum
Members of the @medicine_maker 's 2026 #PowerList have strategies for how to navigate today's cell and gene therapy landscape. Read their thoughts in "Surviving the Squeeze." https://t.co/03CXCHJP5v
Dr. Jun Takahashi has received the 2026 Ogawa-Yamanaka Stem Cell Prize from @GladstoneInst for his pioneering work translating iPS cell biology into a therapy for Parkinson’s disease. https://t.co/fswa6oIUBL